Login to Your Account



Patent Disclosures


Wednesday, January 22, 2014

Anergis SA, of Epalinges, Switzerland, was issued Japanese patent No. 5389326 for its Contiguous Overlapping Peptide (COP) technology, which is used to develop allergy vaccines.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription